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The Zu¨rich Maxi Mental Status Inventory (Zu¨MAX):
Test-Retest Reliability and Discriminant Validity
in Stroke Survivors
Bernadette C. Tobler-Ammann, MSc,*w Eling D. de Bruin, PhD,wzy Peter Brugger, PhD,8
Rob A. de Bie, PhD,w and Ruud H. Knols, PhD*
Objective: To examine discriminant validity and test-retest reli-
ability of the Zu¨rich maxi mental status inventory (Zu¨MAX) in
patients with stroke.
Background: The Zu¨MAX is a novel domain-speciﬁc cognitive
assessment tool to screen for disturbances in neuropsychological
function. The test can be used in stroke rehabilitation to esti-
mate severity of cognitive impairment. Because evidence for
validity and reliability is lacking, the tool’s clinical use is limited.
Methods:We administered the Zu¨MAX in a test-retest design to
33 community-dwelling stroke survivors, and once to 35 healthy
controls matched for age and sex.
Results: We found signiﬁcant group diﬀerences in subscores for
the cognitive domains of executive functions and language as
well as total score (P=0.001 to 0.004); we did not ﬁnd group
diﬀerences for the domains of praxia (deﬁned as the ability to
perform purposeful actions), visual perception and construction,
or learning and memory. Test-retest reliability of the total score
was good (intraclass correlation coeﬃcient=0.81), with the
individual domain subscores ranging from poor to fair (0.59 to
0.79). The Zu¨MAX could detect changes in patients with low
smallest detectable diﬀerences in executive functions, language,
and praxia (0.05 to 1.49) and total score (0.09).
Conclusion: The Zu¨MAX has moderate to good test-retest reli-
ability. Furthermore, the tool might discriminate between
healthy persons and chronic stroke survivors on three of ﬁve
subscales. The Zu¨MAX shows promise in measuring neuro-
psychological disturbances in stroke survivors; however, further
trials are required with larger samples.
Key Words: stroke, post-stroke cognitive impairment, domain-
speciﬁc, test-retest reliability, discriminant validity
(Cogn Behav Neurol 2016;29:78–90)
ICC=intraclass correlation coeﬃcient. MMSE=Mini-Mental
State Examination. MoCA=Montreal Cognitive Assessment.
SDD=smallest detectable diﬀerence. SEM=standard error of
measurement. Zu¨MAX=Zu¨rich maxi mental status inventory.
Cognitive impairment is common after stroke. Im-proving cognition is the highest clinical and research
priority after stroke for patients, their caregivers, and
health professionals (Pollock et al, 2012, 2014).
Rates of post-stroke cognitive impairment diﬀer
widely in the literature, depending on the group studied
(eg, hospital-based versus population-based cohorts),
criteria for cognitive impairment (eg, with or without pre-
or post-stroke dementia or degenerative, vascular, or
mixed cognitive disease), and the time between onset of
stroke and testing (Blackburn et al, 2013; Brainin et al,
2015; Ihle-Hansen et al, 2011; Jacquin et al, 2014; Makin
et al, 2013; Middleton et al, 2014; Sun et al, 2014).
A recent systematic review of domain-speciﬁc cog-
nitive impairment in stroke revealed that impaired cog-
nition involved all major cognitive domains (Edwards
et al, 2013). To date, however, research evidence is in-
suﬃcient to support clear recommendations for clinical
practice, as post-stroke cognitive impairment is diﬃcult to
treat and manage (Gillespie et al, 2015).
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The crucial ﬁrst step in managing cognitive prob-
lems is recognition and diagnosis, with baseline cognitive
testing for screening or triage. Depending on the results,
patients can be oﬀered specialist assessment to deﬁne the
cognitive problem more precisely (Lees et al, 2013).
Standardized assessment batteries and cognitive
screening tools play an important role in identifying un-
derlying cognitive strengths and deﬁcits in survivors of
stroke (Van Heugten et al, 2015). Previous studies have
provided comprehensive comparisons of the utility and
psychometric properties of such tools (Van Heugten et al,
2015). One of the most widely used is the Montreal
Cognitive Assessment (MoCA) (Nasreddine et al,
2005). Burton and Tyson (2015) consider the MoCA “the
most valid and clinically feasible screening tool to identify
stroke survivors with a wide range of cognitive im-
pairments.” The Mini-Mental State Examination
(MMSE) (Folstein et al, 1975) is widely used for quick
dementia screening (Burton and Tyson, 2015).
The MMSE and the majority of other screening tools
used to assess post-stroke cognitive impairment were origi-
nally developed to assess age-related cognitive decline. Al-
though they are now also used to screen stroke survivors,
because of their original purpose, which focused on global
impairments, they lack domain-speciﬁc items. This might
explain why many such tools are unable to detect mild
cognitive impairment, an intermediate clinical state that
often progresses to dementia (Petersen et al, 1999). Fur-
thermore, there is no consensus on either a preferred tool to
test for post-stroke cognitive impairment (Lees et al, 2013)
or a preferred timing of assessment (Brainin et al, 2015).
A screening tool for cognition in survivors of one or
more left or right hemispheric strokes must ﬁrst be able to
discriminate between healthy people and those who have
had a stroke (Chen et al, 2013). Testing discriminant
validity for a novel instrument will thus help clinicians
interpret stroke survivors’ performance.
The growing health care burden, and speciﬁcally the
social and economic impact of post-stroke cognitive im-
pairment, necessitates further clinical studies that go be-
yond discriminating between stroke and nonstroke to
evaluating assessments and delineating their abilities to
discriminate between people with and without post-stroke
cognitive impairment. Studies are needed in both acute
and long-term settings, to help clinicians plan and provide
appropriate treatment throughout a patient’s course
(Brainin et al, 2015).
The validity of future trials will depend on the
ability to describe and quantify cognitive changes in
stroke survivors. This ability, in turn, will depend on
robust critical evaluations of the cognitive tests given to
stroke survivors (Brainin et al, 2015; Quinn et al, 2009), as
some commonly used tools may not be suitable for them
(Godefroy et al, 2011). Any appropriate test would have
to be sensitive to common post-stroke impairments such
as diﬃculties in executive functions; thus, the test should
assess diﬀerent cognitive domains.
A new domain-speciﬁc cognitive assessment tool is
the Zu¨rich maxi mental status inventory, nicknamed the
Zu¨MAX. It was developed by author P.B. at the De-
partment of Neurology, University Hospital Zu¨rich, in
2012. His goal was to “maximize” the “Mini”-Mental
State Examination, to create a neuropsychological
screening instrument that would allow a fast (approx-
imately 30 minutes) but highly sophisticated assessment
of the cognitive domains of executive function, language,
praxia, visuoperception and construction, and learning
and memory. Although P.B. designed the Zu¨MAX to be a
quick, convenient ﬁrst test for patients with suspected
neuropsychological deﬁcits of any neurologic origin, the
tool is also suitable for long-term follow-up. The actual
instrument is described in the Methods section.
P.B. modeled the Zu¨MAX on principles described
by Schnider (2004) in his textbook on comprehensive yet
time-eﬃcient assessments in behavioral neurology. P.B.
also incorporated suggestions from Hachinski et al (2006)
that any neuropsychological screening instrument for
vascular cognitive impairment include the domains of
executive function, language, visuospatial perception and
construction, and learning and memory. P.B. added the
ﬁfth domain, praxia, deﬁned as the ability to perform
purposeful actions, because this domain is typically af-
fected by stroke (Buxbaum and Coslett, 2009).
The Zu¨MAX has several advantages over both the
MMSE and the MoCA. First, the Zu¨MAX examines the
domains of perception and language in greater detail.
Second, the Zu¨MAX tests praxia and executive function;
the MMSE does not cover either of these domains, and
the MoCA covers only executive function.
The Zu¨MAX has not yet been published (see
“Limitations and Future Directions” in the Discussion
section). Readers who want to learn more about the tool
or request a research copy can write to Peter Brugger at
peter.brugger@usz.ch.
The only existing evaluation of the Zu¨MAX is an
unpublished 2014 master’s thesis by Andrea Rust at the
University of Zu¨rich (Rust, 2014). Rust assessed norms
and the construct validity of the Zu¨MAX compared with
the MoCA and MMSE in 227 healthy adults. She found
high correlations (P<0.001) between the total scores of
all the assessments.
The current study is the ﬁrst peer-reviewed pub-
lication evaluating the Zu¨MAX. The tool has not been
altered, meaning that we used the same version with our
stroke survivors that Rust used in 2014.
Our purpose in this study was to evaluate whether
the Zu¨MAX would be a valid and reliable assessment for
measuring cognitive impairment in chronic stroke survi-
vors. We aimed to evaluate not only test-retest reliability
and smallest detectable diﬀerence (SDD), but also dif-
ferences in scoring between chronic stroke survivors and
healthy controls.
We hypothesized that the total score and the sub-
scores for the ﬁve cognitive domains would have good
relative reliability, with an intraclass correlation co-
eﬃcient (ICC) Z0.80. Furthermore, we expected the
SDDs (absolute reliability) to be r10% of the mean
average values of the total score and subscores for the ﬁve
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cognitive domains. For discriminant validity, we expected
to ﬁnd signiﬁcant group diﬀerences (Pr 0.05) in the total
scores and cognitive domain subscores.
METHODS
Participants
To recruit patients who had neurologic deﬁcits after
stroke, we contacted 40 outpatient occupational therapy
practices in the canton of Bern, Switzerland. We asked the
occupational therapists to refer patients currently or re-
cently under their care, and we provided a list of admission
criteria for screening the patients. Of the practices we
contacted, 23 either had no access to stroke survivors or did
not want to participate in the study. The remaining 17
practices, which regularly treated stroke survivors, each
referred one to three patients to us between September 2013
and March 2014. (Unfortunately, no data are available
about the patients who were approached but refused to
participate.) Our study coordinator (author B.C.T.-A.)
kept in touch with the participating occupational therapists
to discuss the patients’ eligibility and guarantee their pri-
vacy. Together, the examiner and therapist scheduled the
appointments for the examiner to test the patients.
Through these means, we recruited a consecutive
community-dwelling sample of 33 stroke survivors who
met these eligibility criteria:
 Age older than 18 years
 A stroke diagnosis, conﬁrmed by a physician, at least 6
months before the study
 Ability to speak and understand the German language
 Ability to sit in a chair or wheelchair with a backrest
for up to 60 minutes
 MMSE score Z20 (indicating, at worst, mild vascular
dementia) for people younger than 80 years of age, and
Z16 for people aged 80 years or older (Folstein et al,
1975; Tombaugh et al, 1996)
Exclusion criteria were a diagnosis of a brain injury
other than stroke, a physician’s earlier diagnosis of ne-
glect or aphasia, and a noncontrolled medical condition
such as chronic pain or drug abuse.
We used the Flinders Handedness survey (FLAN-
DERS) (Nicholls et al, 2013) to assess the patients’
handedness.
We recruited a consecutive sample of healthy con-
trols, whom we matched to the age and sex of the pa-
tients. To ﬁnd the controls, we handed out participant
information sheets to colleagues and relatives of the re-
search team, with a request that they further disseminate
the information to other people they knew (snowball
sampling). We needed 33 controls, but this method was so
successful that 35 people volunteered to take part. Be-
cause they fulﬁlled the inclusion criteria, we included all
35 in the control group.
The eligibility criteria for the controls were:
 Age older than 18 years
 No medical condition (such as a stroke or dementia)
that could inﬂuence their cognitive skills
 Ability to speak and understand German
We asked the controls about their handedness, but
we did not test it.
The study was approved by the Ethics Committee
(Kantonale Ethikkommission [KEK]) (KEK-Nr. 119/13)
of the Canton of Bern, Switzerland. All participants gave
their informed consent before entering the study.
Zu¨rich maxi mental status inventory (Zu¨MAX)
The Zu¨MAX is given as an interview. The total ad-
ministration time of 30 minutes includes 5 minutes of in-
structions from the examiner. The examiner needs this
equipment: a Zu¨MAX testing form with one coversheet, 24
stimulus cards (chimerical faces), and several demonstration,
work, and record sheets; a stopwatch; a metronome; and a
plain pencil (no eraser, no ruler) for patients to use.
Before starting the test, the interviewer assesses
patients’ orientation and obtains their demographic data,
including education level. The interviewer also asks pa-
tients to score their mood on a visual analogue scale. The
Zu¨MAX includes this “mood scale” (Figure 1) (Regard
et al, 1982) because mood has a considerable impact on
cognition (Kimura et al, 2000; Narushima et al, 2007).
The Zu¨MAX proﬁles the ﬁve major cognitive do-
mains typically covered in standard neuropsychological
evaluations (Schnider, 2004): language, praxia, learning
and memory, visual perception and construction, and
executive function. The ﬁve domains are assessed in 15
separate tasks, which are given in the following order and
some of which we illustrate in this paper:
1. Visual perception: degraded ﬁgures, unfamiliar
scenes, face
2. Figural ﬂuency (Figure 3)
3. Visuoverbal memory: immediate recall
4. Visuoconstruction: copy ﬁgure (Figure 5)
5. Verbal ﬂuency with letter criterion (Figure 3)
6. Visual-spatial memory: draw ﬁgure from memory
7. Reading aloud and praxia (Figure 2)
8. Writing, calculation in writing, and oral repetition
9. Category ﬂuency (Figure 3)
10 –11. Interference control (two tasks) (Figure 3)
12. Cognitive ﬂexibility (Figure 3)
13. Visuoverbal memory: late recall
14. Nonverbal visual-spatial memory: draw ﬁgure
again from memory
15. Asymmetry in perception: chimerical faces
As noted, some of the tasks test several domains at
once. For example, Figure 2 illustrates a task that assesses
both language and praxia. Some tasks require spoken
responses, and others require responses written or drawn
with pencil and paper, using the dominant hand. Because
many of the tasks are timed, the Zu¨MAX also addresses
speed of information processing.
Participants can score a maximum of 6 points in
each domain, with a total of 30 points representing
optimal function for all ﬁve domains. Figure 3 shows the
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scoring for the domain of executive function and brieﬂy
explains the component tasks.
Immediately after completing the Zu¨MAX, the in-
terviewer notes how long it took and characterizes both
qualitatively and quantitatively the patient’s orientation,
alertness, tempo, ability to cooperate, aﬀect, and com-
municative behavior.
Procedures
We assessed the patients in the stroke group either at
their occupational therapist’s clinic or in their home. We
tested the patients twice. During the ﬁrst session, we col-
lected the demographic data and gave the MMSE and the
FLANDERS. Then we administered the Zu¨MAX. As in-
structed, participants used their dominant hand to perform
the writing and drawing tasks. During the second session, we
repeated the Zu¨MAX. We spaced the two sessions about a
week apart (mean 6.4 days±1.0 standard deviation) to
minimize the eﬀect of any learning or memory that might
inﬂuence a patient’s performance on the repeat test.
We did not try to give the patients a thorough
neuropsychological evaluation. The patients’ treating
physician did not request this, and asking for such a
service or providing it ourselves would have been beyond
our scope.
After ﬁnishing the test-retest procedure with a pa-
tient, we recruited and tested an age- and sex-matched
control participant. We tested the controls at a place of
their choosing; most chose their home. At the controls’
one testing session, we gathered their demographic data
and asked about their handedness. We gave them the
Zu¨MAX only once, to evaluate its discriminant validity.
The examiners were author B.C.T.-A. and master’s
student Judith Ha¨berli (J.H.). Author P.B. had trained
them to administer the Zu¨MAX. The same examiner did
the test and retest of an individual patient. The examiners
divided up the testing of the controls depending on their
availability.
Statistical Design
We used SPSS version 22.0 (SPSS Inc, Chicago,
Illinois) for data management, and MedCalc statistical
software version 14.8.1 (http://www.medcalc.org) to draw
FIGURE 1. Affect: Self-reporting mood scale of the Zu¨MAX
inventory, in English translation. Participants rate both their
current mood and their best recollection of their affective state
before they suffered their stroke. The examiner rates the value
from 6 to +6.
What finger movements does use
of the black object require?
(Demonstrate this by pantomime)   
FIGURE 2. Reading aloud and praxia: Zu¨MAX demonstration
sheet for a task in the domains of language and praxia, in
English translation. Participants are asked to read the in-
struction aloud and then act on it. Then they are given four
more actions to pantomime, and must act on them.
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FIGURE 3. Scoring for the Zu¨MAX executive function domain, in English translation, with task descriptions.
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Bland-Altman plots. We set the level of statistical sig-
niﬁcance at Pr0.05.
We used descriptive statistics to deﬁne the study
population and their clinical characteristics. We calcu-
lated normality of the data using the Shapiro-Wilk test
for small sample sizes (n<50) (Norman and Streiner,
2008). Our discriminant validity parameters were the
subscores for the ﬁve cognitive domains and the total test
score. We determined testing diﬀerences between the
stroke and control groups with the Mann-Whitney U test
(Norman and Streiner, 2008).
We calculated eﬀect size using the formula for
nonparametric tests:
r ¼ Zﬃﬃﬃ
n
p
(Z being the converted U score) (Fritz et al, 2012). We
then used the eﬀect size estimate r to calculate Cohen d
value:
d ¼ 2r/
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ð1r2Þ
p
We calculated the 95% conﬁdence intervals for ef-
fect size (Ivarsson et al, 2013). Cohen’s (1988) guidelines
for d and r are large eﬀect (d=0.80; r=0.37), medium
(d=0.50; r=0.24), and small (d=0.20; r=0.10).
We analyzed relative reliability by calculating ICCs
separately for single measures using the ICC2(A,1) formula
(Shrout and Fleiss, 1979; Weir, 2005). We selected the
option “absolute agreement” to take into account the
systematic error between raters B.C.T.-A. and J.H. (de Vet
et al, 2006). We used the following criteria for reliability:
high, 0.90 to 0.99; good, 0.80 to 0.89; fair, 0.70 to 0.79; and
poor, r0.69 (Arnall et al, 2002; Denegar and Ball, 1993).
To calculate absolute reliability, we complemented
the ICCs with Bland-Altman analysis, which can be used
to show variation or the magnitude of diﬀerence of re-
peated measurements (Rankin and Stokes, 1998). We
measured the degree of heteroscedasticity by calculating
the Kendall tau correlation between the absolute diﬀer-
ences and the corresponding means of the reliability pa-
rameter. When we found a positive t>0.1, we considered
the data to be heteroscedastic. When the Kendall tau was
<0.1 or negative, we considered the data homoscedastic
(Brehm et al, 2012). When we found heteroscedasticity,
we transformed the data logarithmically (Bland and
Altman, 1996; Euser et al, 2008). Then we calculated the
Kendall tau again; if tlog decreased, we analyzed reli-
ability using the log-transformed parameters (Brehm
et al, 2012).
To quantify the precision of individual scores on an
assessment, we calculated the standard error of mea-
surement (SEM) with the following formula:
SEMagreement ¼ s
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ð1ICCÞ
p
with s being the total variance of the scores from all
participants (de Vet et al, 2006; Weir, 2005). We then
calculated the SDD based on the SEM:
SDD ¼ SEM 1:96
ﬃﬃﬃ
2
p
Here 1.96 deﬁnes the 95% conﬁdence interval. The factorﬃﬃﬃ
2
p
is included because it concerns the diﬀerence between
the two measurements.
As a last step, we calculated the SDD %:
SDD% ¼ SDD
grandmean
 100
The grand mean is the mean of the means of each
Zu¨MAX parameter. Because agreement parameters
(SDDs) are expressed on the actual scale of the assess-
ments, they allow clinical interpretation of the results (de
Vet et al, 2006; Weir, 2005). The SDD % can be used to
compare test-retest reproducibility among tests (Chen
et al, 2009).
RESULTS
All patients and controls completed the
study. Table 1 lists the participants’ demographic and
clinical characteristics. Of our 33 stroke survivors, 29
(87.8%) had suﬀered one stroke and four (three men and
one woman) (12.1%) had sustained at least two strokes.
Table 2 presents the two study groups’ Zu¨MAX
scores, including the total testing time and scores for self-
evaluation of mood. The results of the Shapiro-Wilk test
(Norman and Streiner, 2008) showed no normal dis-
tribution.
Discriminant Validity
In addition to the Zu¨MAX results, Table 2 presents
the group diﬀerences. Descriptive statistics showed that
the controls scored higher in all ﬁve cognitive domains
and in the total score. For example, for the domain ex-
ecutive function, the patients’ median and mean rank
scores were 5 and 28.3 versus the controls’ 6 and 40.3. The
Mann-Whitney U value was signiﬁcant: U=369.5
(Z=0.29), P=0.004. The diﬀerence between groups was
small: eﬀect size r=0.04; d=0.08.
Overall, we found a signiﬁcant diﬀerence between
the two groups in three of the six measures: executive
function, language, and total test score (P-values ranging
from 0.001 to 0.004). The other three domains (praxia,
visual perception and construction, and learning and
memory) had no signiﬁcant diﬀerences between the
groups (P=0.075 to 0.386). We found a small to medium
eﬀect size in the cognitive domains (r ranging from 0.04 to
0.22; d from 0.08 to 0.44) and a large eﬀect size for the
total score (r=0.40, d=0.95).
Test-Retest Reliability
Table 3 shows the test-retest reliability of the
Zu¨MAX for the stroke group, and Figure 4 illustrates
the ﬁndings in Bland-Altman plots.
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Our ﬁrst hypothesis, about relative reliability
(ICCZ0.80), was conﬁrmed by virtue of the Zu¨MAX
total score having an ICC of 0.81 (95% conﬁdence in-
terval: 0.64 to 0.90) (Table 3). For subscores, the ICCs
ranged from fair for executive function, language, and
praxia (ICC=0.72 to 0.79), to poor for visual perception
and construction (0.59) and for learning and memory
(0.60).
Our second hypothesis, concerning absolute reli-
ability, was supported in four of the six Zu¨MAX mea-
sures: The SDDs for executive function, language, praxia,
and total score (ranging from 0.05 to 1.49) were all
r10% of the mean average values of the total score and
subscores (Table 3). The SDDs of the two cognitive do-
mains visual perception and construction (SDD=2.16)
and learning and memory (SDD=1.97) exceeded the
expected 10%, forcing us to reject the hypothesis. Cal-
culating Kendall tau revealed that the three measures
(executive function, praxia, and total test score) were
heteroscedastic and therefore needed to be logarithmi-
cally transformed (Table 3).
DISCUSSION
This study evaluated the discriminant validity and
test-retest reliability of the novel cognitive assessment
“Zu¨MAX” in survivors of stroke.
Validity
In the discriminant validity parameters with sig-
niﬁcant group diﬀerences, the stroke group scored on
average 0.7 point lower than the controls for the domain
language, 0.9 point lower for executive function, and 2.7
points lower for the total test score (Table 2). These re-
sults correspond in part to those of Kaya et al (2014), who
compared MoCA scores for 114 patients with mild cog-
nitive impairment and 246 healthy controls. The authors
reported that the most useful domains in discriminating
mild cognitive impairment from normal cognition were
recall, visuospatial, and language.
In the Zu¨MAX, however, the diﬀerences between
groups were nonsigniﬁcant: only 0.1 point for praxia and
0.5 point each for visual perception and construction and
for learning and memory. It is possible that by the time we
TABLE 1. Demographic and Clinical Characteristics of the Stroke and Control Groups
Stroke 
(n = 33)
Control
(n = 35)
Sex (n [%]) 9 (25.7)9 (27.3)Women
26 (74.3)24 (72.7)Men
Mean ± standard deviationAge (years) 63.2 ± 14.7 63.0 ± 14.6
Median (range)
Education (n [%]) University education
Apprenticeship
No completed education
Stated handedness (n [%]) Right
Mixed 
22 (66.7)
0 (0)
11 (33.3)
33 (94.3)
0 (0)
2 (5.7)Left
Handedness according to Flinders Handedness Right (+5 to +10 points)
Mixed (−4 to +4 points)
Left (−10 to −5 points)
22 (66.7)
1 (3.0)
10 (30.3)
Affected hand (n) 19Right
14Left
Affected hand = dominant hand (n [%]) 20 (66%)
Forced to use nondominant hand because of stroke (n) 8
Months since onset of stroke Mean ± standard deviation
Median (range)
19 (57.6)LeftHemisphere affected by stroke (n [%])
14 (42.4)Right
Mini-Mental State Examination2 score Mean ± standard deviation
Median (range)
66 (33 to 89) 67 (33 to 85)
6 (18.2) 20 (57.1)
24 (72.7) 15 (42.9)
3 (9.1) 0 (0)
22 (6 to 387)
49.4 ± 79.8
27.4 ± 2.3
28 (18 to 30)
Survey1 (n [%])
(maximum, 30 points; ≥ 24 points = normal3)
1Nicholls et al, 2013. 2Folstein et al, 1975. 3Burton and Tyson, 2015.
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recruited our sample of stroke survivors, they had already
recovered almost completely in these domains and thus
reached near-perfect scores, creating a ceiling eﬀect.
A test is considered to have ﬂoor or ceiling eﬀects if
>15% of the respondents score the minimum or max-
imum (Terwee et al, 2007). When we checked for such
eﬀects in the Zu¨MAX, we found no ﬂoor eﬀects but we
saw ceiling eﬀects in all three cognitive domains with
nonsigniﬁcant group diﬀerences. For praxia, for example,
84.9% of our stroke group scored the full 6 points, as did
91.4% of the controls. For the total score, 34.3% of the
controls scored the full 30 points (and 25.7% reached 29
points), while only 6.1% of the stroke sample scored the
maximum (and 30.3% reached 29 points). These ceiling
eﬀects make it impossible to distinguish among partici-
pants who had perfect scores, indicating limited validity.
Still, it seemed important for the Zu¨MAX to have a
maximum of 6 points for each of the ﬁve relevant neuro-
psychological domains. This would make the total scale
score of 30 points comparable to other cognitive screening
instruments, especially the MMSE and MoCA, both of
which also have a maximum score of 30. Before this
scoring is made ﬁnal for the Zu¨MAX, however, the scale
should be examined in larger samples of stroke survivors
and healthy controls, correcting for possible confounding
factors such as cognitive status, to ﬁnd out if ceiling eﬀects
remain.
We found that our stroke group needed on average
of 5.1 minutes longer than the controls to perform the
Zu¨MAX (Table 2). Needing more time to complete an
assessment requires a longer period of concentration,
disadvantageous in a population most of whose members
TABLE 2. Zu¨MAX Scores and Statistical Differences Between the Stroke and Control Groups
Domain
(Maximum Points) Unit 
Stroke 
(n = 33)
Control 
(n = 35) Z-score
Mann-Whitney 
U Test
(P = 0.05)
Effect Size r and d
(95% Confidence 
Interval)
Test Retest Test Stroke Versus Control 
Executive function (6) Mean ± SD 4.7 ± 1.4 5.0 ± 1.3 5.6 ± 0.7
0.29 0.004
0.04
(–0.20 to 0.28)
0.08
(0.04 to 0.12)
Median (range) 5 (1 to 6) 5 (2 to 6) 6 (3 to 6)
Mean rank 28.33 NA 40.31
Language (6) Mean ± SD 5.1 ± 1.1 5.1 ± 1.2 5.8 ± 0.5
2.95 0.003
0.04
(–0.20 to 0.28)
0.08
(0.04 to 0.12)
Median (range) 5 (2 to 6) 5 (1 to 6) 6 (4 to 6)
Mean rank 28.33 NA 40.31
Praxia (6) Mean ± SD 5.8 ± 0.5 5.8 ± 0.4 5.9 ± 0.3
0.87 0.386
0.11
(–0.13 to 0.35)
0.22
(0.18 to 0.26)
Median (range) 6 (4 to 6) 6 (5 to 6) 6 (5 to 6)
Mean rank 33.30 NA 35.63
Visual perception and
construction (6)
Mean ± SD 4.7 ± 1.4 5.1 ± 1.1 5.2 ± 0.9
1.50 0.134
0.18
(–0.06 to 0.42)
0.37
(0.33 to 0.41)
Median (range) 5 (0 to 6) 5 (1 to 6) 5 (3 to 6)
Mean rank 31.00 NA 37.80
Learning and memory (6) Mean ± SD 5.4 ± 1.2 5.6 ± 1.1 5.9 ± 0.4
1.78 0.075
0.22
(–0.02 to 0.46)
0.44
(0.40 to 0.48)
Median (range) 6 (2 to 6) 6 (1 to 6) 6 (5 to 6)
Mean rank 31.32 NA 37.50
Total score (30) Mean ± SD 25.7 ± 3.9 26.6 ± 3.4 28.4 ± 1.9
3.33 0.001
0.40
(0.16 to 0.64)
0.95
(0.91 to 0.99)
Median (range) 26 (14 to 30) 28 (13 to 30) 29 (23 to 30)
Mean rank 26.42 NA 42.11
Test duration
(minutes) Mean ± SD 33.8 ± 6.6 28.6 ± 6.2 28.7 ± 6.5
Median (range) 35 (20 to 50) 30 (20 to 40) 30 (20 to 50)
Self-evaluation of mood
(scale from –6 to 6) Mean ± SD 3.9 ± 2.2 4.2 ± 2.3 4.4 ± 1.3
Median (range) 4 (–1 to 6) 5 (–1 to 6) 5 (1 to 6)
NA=not applicable. SD=standard deviation.
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TABLE 3. Test-Retest Reliability of the Zu¨MAX Subscores and Total Score in the Stroke Group (n=33)
Kendall Tau
5.0 ± 1.3
0.7 ± 0.1
5.1 ± 1.2
5.8 ± 0.4
0.8 ± 0.03
5.1 ± 1.1
5.6 ± 1.1
Test
Mean ± SD
Retest
Mean ± SD
Test-Retest Mean
Difference ± SD
Intraclass
Correlation
Coefficient (95%
Confidence Interval)
Standard Error
of Measurement
AgreementCorrelation
Correlation with
Log-Transformed
Data
Smallest
Detectable
Difference
No. (%)
Domain
(Maximum Points)
Executive function (6)
Language (6)
Praxia (6)
Visual perception and
construction (6)
Learning and memory (6)
Total score (30)
4.7 ± 1.4
0.7 ± 0.2
5.1 ± 1.1
5.8 ± 0.5
0.8 ± 0.04
4.7 ± 1.4
5.4 ± 1.2
25.7 ± 3.9
1.4 ± 0.08
26.6 ± 3.4
1.4 ± 0.07
– 0.24 ± 0.97
– 0.03 ± 0.77
– 0.03 ± 0.30
– 0.36 ± 1.08
– 0.21 ± 1.00
– 0.88 ± 2.25
0.30*
0.96*
0.15*
0.05
0.05
0.26*
0.16†
0.99
0.14†
NA
NA
0.24†
0.69
0.08
0.53
0.21
0.02
0.78
0.71
1.66
0.03
1.92 (39.48)
0.21 (31.72)
1.49 (28.99)
0.59 (10.08)
2.16 (44.49)
1.97 (35.89)
4.61 (17.65)
0.05 (6.54)
0.09 (6.37)
0.73 (0.53 to 0.86)
0.79 (0.62 to 0.89)
0.74 (0.53 to 0.86)
0.59 (0.31 to 0.77)
0.60 (0.34 to 0.78)
0.79 (0.61 to 0.89)
0.78 (0.60 to 0.88)
0.72 (0.50 to 0.85)
0.81 (0.64 to 0.90)
Bold type indicates log10-transformed heteroscedastic parameters.
*t>0.1 indicates heteroscedastic data.
wtlog decreased.
SD=standard deviation. NA=not applicable (because t<0.1).
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likely have cognitive deﬁcits (Van Heugten et al, 2015).
One reason for the prolonged test could be impairments
in patients’ information processing speed, a domain often
aﬀected after stroke (Edwards et al, 2013; Middleton et al,
2014). Another reason is that 66% of our stroke sample
had to perform the Zu¨MAX writing tasks using their
aﬀected hand as the dominant hand.
Furthermore, the stroke group self-rated their mood
an average of 0.5 point lower than the controls (Table 2).
There is evidence that mood can aﬀect cognition and that
Praxia Visual perception and construction
Learning and memory Total score
-2.1
-0.2
Executive function
+1.96 SD
-1.96 SD
Mean
1.7
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-2.5
1 3 4 6 752
1 7
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FIGURE 4. Bland-Altman plots of the five Zu¨MAX cognitive domain subscores and total score. The plots for executive function,
praxia, and total score showed a heteroscedastic data distribution, and therefore needed to be transformed logarithmically for
further analysis. Because many of the 33 stroke survivors shared the same score, fewer than 33 data points are visible in each plot;
the overlap is most obvious in the praxia plot, which has only 5 data points, all falling between 4 and 6 (mean=5.8 points) in the
test and retest. The plots for executive function, visual perception and construction, learning and memory, and total score all
showed a trend toward a slight improvement on the retest. Almost all domains had visible within-group differences, with outliers.
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depression is quite common after stroke (Kimura et al,
2000; Narushima et al, 2007). This might explain our
stroke sample’s lower self-assessment on the mood scale
and their slowed and less accurate test performance.
It is also well known that education has a main
eﬀect on cognitive assessment scores, while sex does not
(Kaya et al, 2014). We suggest correcting the Zu¨MAX for
education eﬀects, eg, by adding one point to the total
score of participants who have at most 12 years of edu-
cation, as is done with the MoCA (Nasreddine et al,
2005; Pendlebury et al, 2010).
In our study, the control group was much more
educated than the patients (Table 1). We were unable to
correct for these education diﬀerences, however, for two
main reasons. First, our older participants in particular
could not remember exactly how many years of education
they had, and we were reluctant to include estimations in
our study. Second, most participants, especially those with
a university degree or apprenticeship, shared an attitude of
life-long learning and had attended several continuing
education programs, thus making it impossible for us to
determine a true cutoﬀ for years of education. To address
this problem, we recommend considering education in the
inclusion criteria of future studies.
Reliability
The Zu¨MAX showed fair to good reliability in four
of the six measures, the exceptions being the domains
visual perception and construction (ICC=0.59) and
learning and memory (ICC=0.60). In the visual per-
ception and construction domain, copying a 10-element
ﬁgure (Figure 5) may have been subject to learning eﬀects
despite our eﬀort to prevent them by spacing the test and
retest about a week apart. Likewise, in the learning and
memory domain, the break between test sessions may not
have been long enough to prevent a learning eﬀect.
The other three cognitive domains (executive func-
tion, language, and praxia) and the total score, all of
which had fulﬁlled our ﬁrst hypothesis, had generally
good test-retest reliability. Their low SDDs indicate that
the Zu¨MAX is sensitive to individual change (Lexell and
Downham, 2005).
Our ICCs were lower than those of other cognitive
assessments, eg, the MoCA. The MoCA’s test-retest
reliability for patients with cerebrovascular disease was
good, ranging from 0.75 to 0.96 (Tu et al, 2013). However,
it is unclear which ICC formula Tu and colleagues applied
in their statistics. This might be of importance in inter-
preting the results, as we used single measures (ICC 2,1
formula) to calculate our ICCs, which might have given us
lower ICCs than if we had used averages for calculation (eg,
ICC 2,k formula) (Shrout and Fleiss, 1979; Weir, 2005).
Limitations and Future Directions
Our study had some limitations. First, we should
emphasize that conclusions about the sensitivity of the
Zu¨MAX must await larger investigations that include
both a population with cognitive deﬁcits and a com-
parable population of matched healthy participants.
Second, we could have used stricter inclusion and
exclusion criteria to minimize heterogeneity between and
within the stroke and control groups. For example,
stricter criteria could distinguish between survivors of a
ﬁrst-ever or a recurrent stroke, as well as among patients
with diﬀerent subtypes of mild cognitive impairment
(vascular, degenerative, mixed). With stricter criteria, we
could also stratify the sample by age group, education
level, or time since stroke onset, and we could consider
pre-stroke cognitive decline (Brainin et al, 2015).
Third, accessing and assessing our patients’ exact
stroke diagnosis and medical history was diﬃcult because
some of the patients had suﬀered their stroke many years
earlier.
A possible ﬁnal limitation was our small sample size,
which may have aﬀected the values of reliability and
measurement error. While the guidelines by Kottner et al
(2011) would consider a sample size of 50 as adequate for
our purpose, we think that our sample of 33 patients was of
reasonable size in this ﬁrst attempt to evaluate the general
usefulness of the Zu¨MAX in patients with chronic stroke.
We see several directions for future research. One idea
is to evaluate the value of the Zu¨MAX for patients during
the acute phase of their stroke, or for an entirely diﬀerent
population, such as people with traumatic brain injury.
Cutoﬀ scores have not yet been established for this
novel instrument, unlike other similar tools such as the
MMSE (Z24 points=normal according to Burton and
Tyson, 2015) or the MoCA (>26 points=normal)
Copy the geometric figure as well as
you can and try to remember it!
FIGURE 5. Visuoconstruction and speed of information pro-
cessing: Zu¨MAX worksheet for a task in the domain of visual
perception and construction, in English translation. Partici-
pants are asked to copy the geometric figure as accurately as
they can and to memorize it for later. They are told that
“beauty doesn’t matter.” What does matter is that they draw
the entire figure with all the parts in the right places and in
approximately correct proportions. Participants earn one point
for each of these elements: (1) the big rectangle, (2) a cor-
rectly placed small triangle, (3) the horizontal middle line, (4)
the small rectangle on the far right side, (5) the “plus” sign in
the upper left corner, (6) the three small diagonal lines in the
lower left corner, (7) the oval, (8) the vertical line tangent to
the left side of the oval, (9) the lower diagonal line, and (10)
the upper diagonal line. One point is deducted for each
markedly displaced or confabulated added element.
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(Dong et al, 2010; Nasreddine et al, 2005). More work is
required here.
It would also be valuable to evaluate the Zu¨MAX’s
ecological validity, deﬁned as the degree to which results ob-
tained under experimental conditions relate to those obtained
in natural environments (Tupper and Cicerone, 1990). Chay-
tor and Schmitter-Edgecombe (2003) reviewed the research on
ecological validity of neuropsychological tests, and concluded
that many instruments oﬀer moderate ability to predict pa-
tients’ everyday cognitive function; the limitation of many tests
is that they do not target individual cognitive domains that
reﬂect speciﬁc aspects of daily function. However, it is unclear
from the literature how strong the relationship between neu-
ropsychological tests and measures of everyday function
should be for a test to be considered ecologically valid.
To extend its reach, the Zu¨MAX could be digitized
and integrated into a virtual exercise program for stroke
survivors, allowing them to follow their progress when
exercising independently at home so that they could further
improve their upper limb motor and cognitive skills.
Finally, to increase awareness of the Zu¨MAX
among clinicians, the tool should be translated into other
languages. As of May 2016, author P.B. had written an
English-language version of the test manual for clinicians,
and he was planning a German-language publication on
normative data for the Zu¨MAX in healthy adults. Author
B.C.T.-A. had been involved with a Spanish-language
translation, which was being tested in stroke survivors in
Seville, Spain. There was no plan to publish the original
German-language version of the test and manual.
In summary, the Zu¨MAX is a brief, yet compre-
hensive, domain-speciﬁc cognitive assessment for measur-
ing disturbances of neuropsychological function in patients
with chronic stroke. The instrument shows moderate to
good reliability. In this preliminary study, the total test
score showed better results than the subscores for the ﬁve
single cognitive domains measured. The domains of exec-
utive function, language, and praxia showed fair reliability;
the domains of learning and memory and of visual per-
ception and construction showed poor reliability. As for
discriminative validity, the Zu¨MAX might discriminate
chronic stroke survivors from healthy controls on the three
subscales of executive function, language, and learning and
memory, as well as on the total score. In conclusion, our
study indicates that the Zu¨MAX can be used as a single
direct assessment to provide a “snapshot” of the current
state of cognition in survivors of chronic stroke, but further
research is required with larger sample sizes.
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